APO Research
Talk to an analyst

APO RESEARCH · REPORT

Swine Live Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Swine Live Vaccine Market Outlook and Growth Opportunities 2026

31 December 2025190 pages

Choose your research edition.

Industry ResearchSwine Live Vaccine Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Live Vaccine Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Swine Live Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Live Vaccine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Live Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Swine Live Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Swine Live Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Swine Live Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Swine Live Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Swine Live Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Swine Live Vaccine market include Boehringer Ingelheim, Ceva Corporate, KM Biologics, Nisseiken, DHN, Harbin Pharmaceutical Group Bio-vaccine, Jinyu Biotechnology, Qindao Lijian Bio-Tech and Shenzhen BIOCBD Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Swine Live Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Swine Live Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Swine Live Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Swine Live Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Swine Live Vaccine Segment by Company

Boehringer Ingelheim

Ceva Corporate

KM Biologics

Nisseiken

DHN

Harbin Pharmaceutical Group Bio-vaccine

Jinyu Biotechnology

Qindao Lijian Bio-Tech

Shenzhen BIOCBD Biotechnology

Wuhan Keqian Biology

Zhongmu Industry

Swine Live Vaccine Segment by Type

Swine Fever Vaccine

Porcine Reproductive and Respiratory Syndrome Vaccine

Pseudorabies Vaccine

Others

Swine Live Vaccine Segment by Application

Breeding Farm

Veterinary Clinic

Swine Live Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Swine Live Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Swine Live Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Swine Live Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Swine Live Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Live Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Live Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Live Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Swine Live Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Swine Live Vaccine industry.

Chapter 3: Detailed analysis of Swine Live Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Swine Live Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Swine Live Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Swine Live Vaccine Industry Trends Table 2. Swine Live Vaccine Industry Drivers Table 3. Swine Live Vaccine Industry Opportunities and Challenges Table 4. Swine Live Vaccine Industry Restraints Table 5. Global Swine Live Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Swine Live Vaccine Revenue Share by Company (2021-2026) Table 7. Global Swine Live Vaccine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Swine Live Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Swine Live Vaccine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Swine Live Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Swine Live Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Swine Live Vaccine Company, Product Type & Application Table 13. Global Swine Live Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Swine Live Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Swine Fever Vaccine Table 18. Significant Companies of Porcine Reproductive and Respiratory Syndrome Vaccine Table 19. Significant Companies of Pseudorabies Vaccine Table 20. Significant Companies of Others Table 21. Global Swine Live Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Swine Live Vaccine Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Swine Live Vaccine Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Swine Live Vaccine Sales Volume Share by Type (2021-2026) Table 25. Global Swine Live Vaccine Sales Volume Share by Type (2027-2032) Table 26. Global Swine Live Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Swine Live Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Swine Live Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Swine Live Vaccine Sales Value Share by Type (2021-2026) Table 30. Global Swine Live Vaccine Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Breeding Farm Table 32. Significant Companies of Veterinary Clinic Table 33. Global Swine Live Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Swine Live Vaccine Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Swine Live Vaccine Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Swine Live Vaccine Sales Volume Share by Application (2021-2026) Table 37. Global Swine Live Vaccine Sales Volume Share by Application (2027-2032) Table 38. Global Swine Live Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Swine Live Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Swine Live Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Swine Live Vaccine Sales Value Share by Application (2021-2026) Table 42. Global Swine Live Vaccine Sales Value Share by Application (2027-2032) Table 43. Global Swine Live Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Swine Live Vaccine Sales by Region (2021-2026) & (K Units) Table 45. Global Swine Live Vaccine Sales Market Share by Region (2021-2026) Table 46. Global Swine Live Vaccine Sales by Region (2027-2032) & (K Units) Table 47. Global Swine Live Vaccine Sales Market Share by Region (2027-2032) Table 48. Global Swine Live Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Swine Live Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Swine Live Vaccine Sales Value Share by Region (2021-2026) Table 51. Global Swine Live Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Swine Live Vaccine Sales Value Share by Region (2027-2032) Table 53. Global Swine Live Vaccine Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Swine Live Vaccine Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Swine Live Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Swine Live Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Swine Live Vaccine Sales by Country (2021-2026) & (K Units) Table 58. Global Swine Live Vaccine Sales Market Share by Country (2021-2026) Table 59. Global Swine Live Vaccine Sales by Country (2027-2032) & (K Units) Table 60. Global Swine Live Vaccine Sales Market Share by Country (2027-2032) Table 61. Global Swine Live Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Swine Live Vaccine Sales Value Market Share by Country (2021-2026) Table 63. Global Swine Live Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Swine Live Vaccine Sales Value Market Share by Country (2027-2032) Table 65. Boehringer Ingelheim Company Information Table 66. Boehringer Ingelheim Business Overview Table 67. Boehringer Ingelheim Swine Live Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Boehringer Ingelheim Swine Live Vaccine Product Portfolio Table 69. Boehringer Ingelheim Recent Development Table 70. Ceva Corporate Company Information Table 71. Ceva Corporate Business Overview Table 72. Ceva Corporate Swine Live Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Ceva Corporate Swine Live Vaccine Product Portfolio Table 74. Ceva Corporate Recent Development Table 75. KM Biologics Company Information Table 76. KM Biologics Business Overview Table 77. KM Biologics Swine Live Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. KM Biologics Swine Live Vaccine Product Portfolio Table 79. KM Biologics Recent Development Table 80. Nisseiken Company Information Table 81. Nisseiken Business Overview Table 82. Nisseiken Swine Live Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Nisseiken Swine Live Vaccine Product Portfolio Table 84. Nisseiken Recent Development Table 85. DHN Company Information Table 86. DHN Business Overview Table 87. DHN Swine Live Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. DHN Swine Live Vaccine Product Portfolio Table 89. DHN Recent Development Table 90. Harbin Pharmaceutical Group Bio-vaccine Company Information Table 91. Harbin Pharmaceutical Group Bio-vaccine Business Overview Table 92. Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Product Portfolio Table 94. Harbin Pharmaceutical Group Bio-vaccine Recent Development Table 95. Jinyu Biotechnology Company Information Table 96. Jinyu Biotechnology Business Overview Table 97. Jinyu Biotechnology Swine Live Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Jinyu Biotechnology Swine Live Vaccine Product Portfolio Table 99. Jinyu Biotechnology Recent Development Table 100. Qindao Lijian Bio-Tech Company Information Table 101. Qindao Lijian Bio-Tech Business Overview Table 102. Qindao Lijian Bio-Tech Swine Live Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Qindao Lijian Bio-Tech Swine Live Vaccine Product Portfolio Table 104. Qindao Lijian Bio-Tech Recent Development Table 105. Shenzhen BIOCBD Biotechnology Company Information Table 106. Shenzhen BIOCBD Biotechnology Business Overview Table 107. Shenzhen BIOCBD Biotechnology Swine Live Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Shenzhen BIOCBD Biotechnology Swine Live Vaccine Product Portfolio Table 109. Shenzhen BIOCBD Biotechnology Recent Development Table 110. Wuhan Keqian Biology Company Information Table 111. Wuhan Keqian Biology Business Overview Table 112. Wuhan Keqian Biology Swine Live Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Wuhan Keqian Biology Swine Live Vaccine Product Portfolio Table 114. Wuhan Keqian Biology Recent Development Table 115. Zhongmu Industry Company Information Table 116. Zhongmu Industry Business Overview Table 117. Zhongmu Industry Swine Live Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Zhongmu Industry Swine Live Vaccine Product Portfolio Table 119. Zhongmu Industry Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Swine Live Vaccine Distributors List Table 123. Swine Live Vaccine Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Swine Live Vaccine Product Image Figure 2. Global Swine Live Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Swine Live Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Swine Live Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Swine Live Vaccine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Swine Live Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Swine Fever Vaccine Image Figure 10. Porcine Reproductive and Respiratory Syndrome Vaccine Image Figure 11. Pseudorabies Vaccine Image Figure 12. Others Image Figure 13. Global Swine Live Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Swine Live Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Swine Live Vaccine Sales Volume Share by Type (2021-2032) Figure 16. Global Swine Live Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Swine Live Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Swine Live Vaccine Sales Value Share by Type (2021-2032) Figure 19. Breeding Farm Image Figure 20. Veterinary Clinic Image Figure 21. Global Swine Live Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Swine Live Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Swine Live Vaccine Sales Volume Share by Application (2021-2032) Figure 24. Global Swine Live Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Swine Live Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Swine Live Vaccine Sales Value Share by Application (2021-2032) Figure 27. Global Swine Live Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Swine Live Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Swine Live Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Swine Live Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Swine Live Vaccine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Swine Live Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Swine Live Vaccine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Swine Live Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Swine Live Vaccine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Swine Live Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Swine Live Vaccine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Swine Live Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Swine Live Vaccine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Swine Live Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Swine Live Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Swine Live Vaccine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Swine Live Vaccine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Swine Fever Vaccine
  • Porcine Reproductive and Respiratory Syndrome Vaccine
  • Pseudorabies Vaccine
  • Others
Applications
  • Breeding Farm
  • Veterinary Clinic
Companies covered
  • Boehringer Ingelheim
  • Ceva Corporate
  • KM Biologics
  • Nisseiken
  • DHN
  • Harbin Pharmaceutical Group Bio-vaccine
  • Jinyu Biotechnology
  • Qindao Lijian Bio-Tech
  • Shenzhen BIOCBD Biotechnology
  • Wuhan Keqian Biology
  • Zhongmu Industry

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Swine Live Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Swine Live Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Swine Live Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Swine Live Vaccine Market Dynamics
  1. 2.1 Swine Live Vaccine Industry Trends
  2. 2.2 Swine Live Vaccine Industry Drivers
  3. 2.3 Swine Live Vaccine Industry Opportunities and Challenges
  4. 2.4 Swine Live Vaccine Industry Restraints
3 Swine Live Vaccine Market by Company
  1. 3.1 Global Swine Live Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Swine Live Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Swine Live Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Swine Live Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Swine Live Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Swine Live Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Swine Live Vaccine Company Product Type and Application
  8. 3.8 Global Swine Live Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Swine Live Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Swine Live Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Swine Live Vaccine Market by Type
  1. 4.1 Swine Live Vaccine Type Introduction
  2. 4.1.1 Swine Fever Vaccine
  3. 4.1.2 Porcine Reproductive and Respiratory Syndrome Vaccine
  4. 4.1.3 Pseudorabies Vaccine
  5. 4.1.4 Others
  6. 4.2 Global Swine Live Vaccine Sales Volume by Type
  7. 4.2.1 Global Swine Live Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Swine Live Vaccine Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Swine Live Vaccine Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Swine Live Vaccine Sales Value by Type
  11. 4.3.1 Global Swine Live Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Swine Live Vaccine Sales Value by Type (2021-2032)
  13. 4.3.3 Global Swine Live Vaccine Sales Value Share by Type (2021-2032)
5 Swine Live Vaccine Market by Application
  1. 5.1 Swine Live Vaccine Application Introduction
  2. 5.1.1 Breeding Farm
  3. 5.1.2 Veterinary Clinic
  4. 5.2 Global Swine Live Vaccine Sales Volume by Application
  5. 5.2.1 Global Swine Live Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Swine Live Vaccine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Swine Live Vaccine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Swine Live Vaccine Sales Value by Application
  9. 5.3.1 Global Swine Live Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Swine Live Vaccine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Swine Live Vaccine Sales Value Share by Application (2021-2032)
6 Swine Live Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Swine Live Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Swine Live Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Swine Live Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Swine Live Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Swine Live Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Swine Live Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Swine Live Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Swine Live Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Swine Live Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Swine Live Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Swine Live Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Swine Live Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Swine Live Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Swine Live Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Swine Live Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Swine Live Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Swine Live Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Swine Live Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Swine Live Vaccine Sales Value Share by Country, 2025 VS 2032
7 Swine Live Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Swine Live Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Swine Live Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Swine Live Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Swine Live Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Swine Live Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Swine Live Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Swine Live Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Swine Live Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Swine Live Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Swine Live Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Swine Live Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Swine Live Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Swine Live Vaccine Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 Ceva Corporate
  8. 8.2.1 Ceva Corporate Company Information
  9. 8.2.2 Ceva Corporate Business Overview
  10. 8.2.3 Ceva Corporate Swine Live Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Ceva Corporate Swine Live Vaccine Product Portfolio
  12. 8.2.5 Ceva Corporate Recent Developments
  13. 8.3 KM Biologics
  14. 8.3.1 KM Biologics Company Information
  15. 8.3.2 KM Biologics Business Overview
  16. 8.3.3 KM Biologics Swine Live Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 KM Biologics Swine Live Vaccine Product Portfolio
  18. 8.3.5 KM Biologics Recent Developments
  19. 8.4 Nisseiken
  20. 8.4.1 Nisseiken Company Information
  21. 8.4.2 Nisseiken Business Overview
  22. 8.4.3 Nisseiken Swine Live Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Nisseiken Swine Live Vaccine Product Portfolio
  24. 8.4.5 Nisseiken Recent Developments
  25. 8.5 DHN
  26. 8.5.1 DHN Company Information
  27. 8.5.2 DHN Business Overview
  28. 8.5.3 DHN Swine Live Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 DHN Swine Live Vaccine Product Portfolio
  30. 8.5.5 DHN Recent Developments
  31. 8.6 Harbin Pharmaceutical Group Bio-vaccine
  32. 8.6.1 Harbin Pharmaceutical Group Bio-vaccine Company Information
  33. 8.6.2 Harbin Pharmaceutical Group Bio-vaccine Business Overview
  34. 8.6.3 Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Product Portfolio
  36. 8.6.5 Harbin Pharmaceutical Group Bio-vaccine Recent Developments
  37. 8.7 Jinyu Biotechnology
  38. 8.7.1 Jinyu Biotechnology Company Information
  39. 8.7.2 Jinyu Biotechnology Business Overview
  40. 8.7.3 Jinyu Biotechnology Swine Live Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Jinyu Biotechnology Swine Live Vaccine Product Portfolio
  42. 8.7.5 Jinyu Biotechnology Recent Developments
  43. 8.8 Qindao Lijian Bio-Tech
  44. 8.8.1 Qindao Lijian Bio-Tech Company Information
  45. 8.8.2 Qindao Lijian Bio-Tech Business Overview
  46. 8.8.3 Qindao Lijian Bio-Tech Swine Live Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Qindao Lijian Bio-Tech Swine Live Vaccine Product Portfolio
  48. 8.8.5 Qindao Lijian Bio-Tech Recent Developments
  49. 8.9 Shenzhen BIOCBD Biotechnology
  50. 8.9.1 Shenzhen BIOCBD Biotechnology Company Information
  51. 8.9.2 Shenzhen BIOCBD Biotechnology Business Overview
  52. 8.9.3 Shenzhen BIOCBD Biotechnology Swine Live Vaccine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Shenzhen BIOCBD Biotechnology Swine Live Vaccine Product Portfolio
  54. 8.9.5 Shenzhen BIOCBD Biotechnology Recent Developments
  55. 8.10 Wuhan Keqian Biology
  56. 8.10.1 Wuhan Keqian Biology Company Information
  57. 8.10.2 Wuhan Keqian Biology Business Overview
  58. 8.10.3 Wuhan Keqian Biology Swine Live Vaccine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Wuhan Keqian Biology Swine Live Vaccine Product Portfolio
  60. 8.10.5 Wuhan Keqian Biology Recent Developments
  61. 8.11 Zhongmu Industry
  62. 8.11.1 Zhongmu Industry Company Information
  63. 8.11.2 Zhongmu Industry Business Overview
  64. 8.11.3 Zhongmu Industry Swine Live Vaccine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Zhongmu Industry Swine Live Vaccine Product Portfolio
  66. 8.11.5 Zhongmu Industry Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Swine Live Vaccine Value Chain Analysis
  2. 9.1.1 Swine Live Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Swine Live Vaccine Sales Mode & Process
  6. 9.2 Swine Live Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Swine Live Vaccine Distributors
  9. 9.2.3 Swine Live Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst